Outcomes of 16-week extension of anti-VEGF therapy in neovascular age-related macular degeneration. Basilious A, Yuan AT, Sheidow TG. Can J Ophthalmol 2025 Oct 31:S0008-4182(25)00443.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Basilious A, Yuan AT, Sheidow TG. Outcomes of 16-week extension of anti-VEGF therapy in neovascular age-related macular degeneration. Can J Ophthalmol 2025 Oct 31:S0008-4182(25)00443.
PMID: 41183785